 Print previewVALIDITY EXPIRED
personal data approved: 2021. VII. 06. | Publications |
2021
 from data base, 2021. VII. 06. |
Urbán László, Dóczi Róbert, Vodicska Barbara, Tihanyi Dóra, Horváth Magdolna, Kormos Dóra, Takács István, Pápai-Székely Zsolt, Póka-Farkas Zsuzsanna, Várkondi Edit, Schwáb Richárd, Hegedüs Csilla, Vályi-Nagy István, Peták István: Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation, CLINICAL LUNG CANCER 22: (1) pp. e112-e115.
type of document: Journal paper/Article
language: English
URL |
2021
from data base, 2021. VII. 06. |
Petak Istvan, Kamal Maud, Dirner Anna, Bieche Ivan, Doczi Robert, Mariani Odette, Filotas Peter, Salomon Anne, Vodicska Barbara, Servois Vincent, Varkondi Edit, Gentien David, Tihanyi Dora, Tresca Patricia, Lakatos Dora, Servant Nicolas, Deri Julia, du Rusquec Pauline, Hegedus Csilla, Bello Roufai Diana, Schwab Richard, Dupain Celia, Valyi-Nagy Istvan T., Le Tourneau Christophe: A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial, NPJ PRECISION ONCOLOGY 5: (1) 59
type of document: Journal paper/Article
language: English
URL |
2020
from data base, 2021. VII. 06. |
Urbán László, Dóczi Róbert, Vodicska Barbara, Kormos Dóra, Tóth László, Takács István, Várkondi Edit, Tihanyi Dóra, Lakatos Dóra, Dirner Anna, Vályi-Nagy István, Peták István: Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC, JOURNAL OF PERSONALIZED MEDICINE 10: (3) p. 107.
type of document:
number of independent citations: 1
language: English
URL |
2019
from data base, 2021. VII. 06. |
Zsákai Lilian, Sipos Anna, Dobos Judit, Erős Dániel, Szántai-Kis Csaba, Bánhegyi Péter, Pató János, Őrfi László, Matula Zsolt, Mikala Gábor, Kéri György, Peták István, Vályi-Nagy István: Targeted drug combination therapy design based on driver genes, ONCOTARGET 10: (51) pp. 5255-5266.
type of document: Journal paper/Article
number of independent citations: 1
language: English
URL |
2019
from data base, 2021. VII. 06. |
Murányi József, Varga Attila, Gyulavári Pál, Pénzes Kinga, Németh Csilla E., Csala Miklós, Pethő Lilla, Csámpai Antal, Halmos Gábor, Peták István, Vályi-Nagy István: Novel Crizotinib–GnRH conjugates revealed the significance of lysosomal trapping in GnRH-based drug delivery systems, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20: (22) 5590
type of document: Journal paper/Article
number of independent citations: 2
language: English
URL |
2017
from data base, 2021. VII. 06. |
Brauswetter D, Gurbi B, Varga A, Varkondi E, Schwab R, Banhegyi G, Fabian O, Keri G, Valyi-Nagy I, Petak I: Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers, PLOS ONE 12: (9) e0185687
type of document: Journal paper/Article
number of independent citations: 12
language: English
URL |
2010
from data base, 2021. VII. 06. |
Petak I, Schwab R, Orfi L, Kopper L, Keri G: Integrating molecular diagnostics into anticancer drug discovery, NATURE REVIEWS DRUG DISCOVERY 9: (7) pp. 523-535.
type of document: Journal paper/Article
number of independent citations: 48
language: English
URL |
2008
from data base, 2021. VII. 06. |
Pinter F, Papay J, Almasi A, Sapi Z, Szabo E, Kanya M, Tamasi A, Jori B, Varkondi E, Moldvay J, Szondy K, Keri G, Dominici M, Conte P, Eckhardt S, Kopper L, Schwab R, Petak I: Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry, JOURNAL OF MOLECULAR DIAGNOSTICS 10: (2) pp. 160-168.
type of document: Journal paper/Article
number of independent citations: 61
language: English
URL |
2001
from data base, 2021. VII. 06. |
Petak I, Houghton JA: Shared pathways: Death receptors and cytotoxic drugs in cancer therapy, PATHOLOGY AND ONCOLOGY RESEARCH 7: (2) pp. 95-106.
type of document: Journal paper/Review paper
number of independent citations: 127
language: English
URL |
2000
from data base, 2021. VII. 06. |
Petak I, Douglas L, Tillman DM, Vernes R, Houghton JA: Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis, CLINICAL CANCER RESEARCH 6: (10) pp. 4119-4127.
type of document: Journal paper/Article
number of independent citations: 77
language: English
|
| | Number of independent citations to these publications: | 329 |
|
|
Login
kps.hu
